Related Experiment Video
Updated: Nov 7, 2025

07:49
Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling
Published on: August 3, 2018
11.5K
The Oncogene Transcription Factor EB Regulates Vascular Functions
Gabriella Doronzo1,2, Elena Astanina1,2, Federico Bussolino1,2
1Department of Oncology, University of Torino, Candiolo, Italy.
Frontiers in Physiology
|April 29, 2021
Summary
Transcription factor EB (TFEB) regulates vascular cell functions, including angiogenesis, inflammation, and atherosclerosis. This review details TFEB
Area of Science:
- Molecular Biology
- Vascular Biology
- Cellular Stress Response
Background:
- Transcription factor EB (TFEB) is a key regulator of lysosomal and autophagosome biogenesis, crucial for cellular adaptation to stress.
- TFEB belongs to the microphthalmia family of transcription factors and is implicated in various cellular processes beyond stress response, including proliferation, metabolism, inflammation, and immunity.
- Dysregulation of TFEB is observed in cancer, highlighting its broader biological significance.
Purpose of the Study:
- To summarize the fundamental principles and activation mechanisms of TFEB's transcriptional program.
- To review the current understanding of TFEB's role in vascular biology.
- To emphasize TFEB's regulatory functions in angiogenesis and its involvement in vascular inflammation and atherosclerosis.
Main Methods:
- Literature review and synthesis of existing research on TFEB.
- Analysis of TFEB's transcriptional targets and regulatory pathways.
- Examination of TFEB's role in cellular processes within the vascular system.
Main Results:
- TFEB orchestrates a canonical pathway for cellular adaptation via lysosomal and autophagosome biogenesis.
- TFEB also modulates non-canonical genetic programs impacting cell proliferation, metabolism, inflammation, and immunity.
- Evidence suggests TFEB plays a significant role in regulating angiogenesis within the vascular system.
Conclusions:
- TFEB is an emerging and critical factor in vascular biology, influencing key processes like angiogenesis.
- The vascular unit's involvement in inflammation and atherosclerosis is modulated by TFEB.
- Further research into TFEB's multifaceted roles in vascular health and disease is warranted.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.4K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.4K
Mitogens and the Cell Cycle
7.3K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Mechanism of Angiogenesis
6.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K
General Transcription Factors
6.2K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.2K
mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K

